A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Masarova, Lucia
  • Reeves, Brandi N
  • El Chaer, Firas
  • Foltz, Lynda
  • Tashi, Tsewang
  • Abu-Zeinah, Ghaith
  • Lucas, Jennifer
  • Halpern, Anna B
  • Maze, Dawn
  • Qin, Albert
  • Safah, Hana
  • Lan, Fengshuo
  • O'Connell, Casey L
  • Goel, Swati
  • Rein, Lindsay
  • Fang, Bruno
  • How, Joan
  • Babu, Sunil
  • Li, Zhuoyan
  • Cerquozzi, Sonia
  • Oh, Stephen T
  • Hunter, Anthony M
  • Podoltsev, Nikolai
  • Vachhani, Pankit
  • Yacoub, Abdulraheem
  • Cunningham, Julia M
  • Hillis, Christopher
  • Otoukesh, Salman
  • Zagrijtschuk, Oleh
  • Castro, Henry
  • Bose, Prithviraj

publication date

  • 2025